Censo Bio

Enabling the discovery and development of new targeted treatments for disease by utilising the power of stem cells. #stemcells #pharma #biotech #DrugDiscovery

[Censo Bio @Censobio]

Staining #iPSC derived #neuralprogenitor cells is one of the many ways we characterise our cells. These can be matured to #neurons and provide a valuable platform for #diseasemodeling and #compoundscreening in #neurodegeneration

[Censo Bio @Censobio]

So cool! Great to see different ways to use the Incucyte

[Dylan Burnette @MAG2ART]

Proliferating cancer cells expressing the Fucci cell cycle sensor. Red is G1 of the cell cycle and green is S through M. The movie shows 2 days of imaging with our #Incucyte S3 from @EssenBioScience. #CellBiology

[Censo Bio @Censobio]

Looking for a CRO with experience in #iPSC derived cell models for pre-clinical research? Censo Bio provides customised #assays and compound screening services in #neuroinflammation & #neurodegeneration to support clients #drugdiscovery programmes.

[Censo Bio @Censobio]

We will be presenting our poster (178) at the @FENS virtual conference tomorrow at 10.30am. Come speak to us and learn more about what we do! #iPSC #microglia #neuroinflammation

[Censo Bio @Censobio]

One day until the #FENS2020 virtual conference! Censo will be presenting a poster on #iPSC derived #macrophages/#microglia for disease modelling on the 12th and 14th of July (poster 178). Looking forward to some great science! #FENS2020poster https://t.co/CZZDw4Tjhz

[Censo Bio @Censobio]

Censo are pleased to have been able to sponsor the prize for top student in Development, regeneration & stem cells. Congratulations to all the 2020 graduates! #EdinburghUni https://t.co/5GjJJh8mPi

[Censo Bio @Censobio]

Some of our #iPSC derived #sensory neurons. These provide a great platform for modeling #pain, #Friedreichs ataxia and more. Also one of our favourites to image!

[Censo Bio @Censobio]

@lifearc1 Fantastic news! Looking forward to seeing all the exciting results

[Censo Bio @Censobio]

Milner symposium 2020 is taking place today. We are excited to attend this virtual conference and present a poster (author Jessica Tilman) #MilnerSymp20

[Censo Bio @Censobio]

BIO One-on-One #Partnering starts today. Meet Censo Biotechnologies and learn more about what we do and what we can offer by setting up a partnering meeting. https://t.co/JLsg8mvRbC #BIODigital

[Censo Bio @Censobio]

Censo Biotechnologies are attending the ISCT 2020 virtual partnering forum (May 28 - June 4). Set up a partnering meeting today and learn more about what we do and what we can offer. https://t.co/1mWN82LN5S

[Censo Bio @Censobio]

#iPSC derived cells generate relevant disease models and provide a platform for #screening. This review shows the benefits of iPSC derived cells and future directions. Censo have experience with #neurons, #astrocytes and #microglia. Contact us for more. https://t.co/iqtFP0jCQq

[Censo Bio @Censobio]

Great video!

[Yoni - יוני (and Rebecca too) @Primary_Immune]

A little bit more "phagocytosis" in action

"Macrophage engulfs foreign cells"

📽️ credit: Dr. Richard Tsai; National Institute of Biomedical Imaging and Bioengineering

[Censo Bio @Censobio]

Another great infographic summarising the current evidence on #COVID19 #biomarkers

[Birmingham Health Partners @BHPComms]

The infographic and summary can be viewed at https://t.co/wKaqMSSn0l, when you can download a PDF of this and our previous #COVID19 research briefings

[Censo Bio @Censobio]

#Macrophages and #monocytes play an important role in fighting any #infection, but can also cause damage when the inflammatory response becomes exaggerated. How could we modulate activation to limit damage while still maintaining key functions?
https://t.co/F93Ivqmbsm

[Censo Bio @Censobio]

Very few drugs have been approved in #neuroscience in the past 10 years, highlighting the need for new #diseasemodels. #IPSC derived cells offer a reproducible and relevant model which can be scaled for #compound screening.

[Ziv Gan-Or @ZivGanOr]

Only 3% of neurological drugs that went into phase I between 2010-2017 were eventually approved. The vast majority are drugs that are very similar to older symptomatic drugs, and almost none of them (maybe 1 drug) is actually treating the disease. https://t.co/wpjU4ItQkU

[Censo Bio @Censobio]

@ZivGanOr @Javier_DiazNido Agreed! Alternative models to animal studies are needed in the field

[Censo Bio @Censobio]

Interesting review on the potential methods used to develop #vaccines against #COVID19 https://t.co/jxTfMIRxMS

[Censo Bio @Censobio]

Amazing to see how much information and data has been generated around #COVID19. This information is so important to understand the disease and how to best prevent, treat and find a vaccine. #Science #research #medicine #pharma

[Censo Bio @Censobio]

@DrmcconnachIe We are well, thanks George. We hope you and your family are too!

[Censo Bio @Censobio]

The Censo team have been working on a new #celltherapy to counter any novel #coronavirus. This would not be specific to any one strain of #virus and could be stockpiled in advance. It's early stage but initial indications are that it could be effective within 12-24h #antivirals